1. Cevenini E, Invidia L, Lescai F, Salvioli S, Tieri P, Castellani G, et al. Human models of aging and longevity. Expert Opin Biol Ther. 2008;8:1393–405. doi:10.1517/14712598.8.9.1393. [PubMed] [CrossRef] [Google Scholar]
2. Uitto J. Understanding premature skin aging. N Engl J Med. 1997;337:1463–5. doi:10.1056/NEJM199711133372011. [PubMed] [CrossRef] [Google Scholar]
3. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science. 2006;312:1059–63. doi:10.1126/science.1127168. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Fisher, G.J. The pathophysiology of photoaging of the skin. Cutis, 75, 5–9 (2005)58–69. [PubMed]
5. Schmuth M, Watson RE, Deplewski D, Dubrac S, Zouboulis CC, Griffiths CE. Nuclear hormone receptors in human skin. Horm Metab Res. 2007;39:96–105. doi:10.1055/s-2007-961808. [PubMed] [CrossRef] [Google Scholar]
6. Reichrath J, Lehmann B, Carlberg C, Varani J, Zouboulis CC. Vitamins as hormones. Horm Metab Res. 2007;39:71–84. doi:10.1055/s-2007-958715. [PubMed] [CrossRef] [Google Scholar]
7. Verdier-Sévrain S, Bonté F, Gilchrest B. Biology of estrogens in skin: implications for skin aging. Exp Dermatol. 2006;15:83–94. doi:10.1111/j.1600-0625.2005.00377.x. [PubMed] [CrossRef] [Google Scholar]
8. Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol. 2005;53:555–68, quiz 569-72. doi:10.1016/j.jaad.2004.08.039. [PubMed] [CrossRef] [Google Scholar]
9. Brincat MP, Baron YM, Galea R. Estrogens and the skin. Climacteric. 2005;8:110–23. doi:10.1080/13697130500118100. [PubMed] [CrossRef] [Google Scholar]
10. Draelos ZD. Topical and oral estrogens revisited for antiaging purposes. Fertil Steril. 2005;84:291–2, discussion 295. doi:10.1016/j.fertnstert.2005.03.033. [PubMed] [CrossRef] [Google Scholar]
11. Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005;38:1–7. doi:10.1016/j.jdermsci.2004.10.011. [PubMed] [CrossRef] [Google Scholar]
12. Shin MH, Rhie GE, Park CH, Kim KH, Cho KH, Eun HC, et al. Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. J Invest Dermatol. 2005;124:315–23. doi:10.1111/j.0022-202X.2004.23588.x. [PubMed] [CrossRef] [Google Scholar]
13. Kligman LH. Photoaging. Manifestations, prevention, and treatment. Clin Geriatr Med. 1989;5:235–51. [PubMed] [Google Scholar]
14. El-Domyati M, Attia S, Saleh F, Brown D, Birk DE, Gasparro F, et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol. 2002;11:398–405. doi:10.1034/j.1600-0625.2002.110502.x. [PubMed] [CrossRef] [Google Scholar]
15. Moragas A, Castells C, Sans M. Mathematical morphologic analysis of aging-related epidermal changes. Anal Quant Cytol Histol. 1993;15:75–82. [PubMed] [Google Scholar]
16. Lock-Andersen J, Therkildsen P, de Fine Olivarius F, Gniadecka M, Dahlstrøm K, Poulsen T, et al. Epidermal thickness, skin pigmentation and constitutive photosensitivity. Photodermatol Photoimmunol Photomed. 1997;13:153–8. doi:10.1111/j.1600-0781.1997.tb00220.x. [PubMed] [CrossRef] [Google Scholar]
17. Makrantonaki E, Zouboulis CC. William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology. 2007;214:352–60. doi:10.1159/000100890. [PubMed] [CrossRef] [Google Scholar]
18. Makrantonaki E, Zouboulis CC. Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci. 2007;1119:40–50. doi:10.1196/annals.1404.027. [PubMed] [CrossRef] [Google Scholar]
19. Escoffier C, de Rigal J, Rochefort A, Vasselet R, Lévêque JL, Agache PG. Age-related mechanical properties of human skin: an in vivo study. J Invest Dermatol. 1989;93:353–7. doi:10.1111/1523-1747.ep12280259. [PubMed] [CrossRef] [Google Scholar]
20. Yaar M, Gilchrest BA. Aging of skin. In Fitzpatrick’s Dermatology in General Medicine Vol 2, 5th edn. McGraw-Hill:New York, 1999; 1697–1706. [Google Scholar]
21. Baumann L. Skin ageing and its treatment. J Pathol. 2007;211:241–51. doi:10.1002/path.2098. [PubMed] [CrossRef] [Google Scholar]
22. Watson RE, Craven NM, Kang S, Jones CJ, Kielty CM, Griffiths CE. A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents. J Invest Dermatol. 2001;116:672–8. doi:10.1046/j.1523-1747.2001.01322.x. [PubMed] [CrossRef] [Google Scholar]
23. Contet-Audonneau JL, Jeanmaire C, Pauly G. A histological study of human wrinkle structures: comparison between sun-exposed areas of the face, with or without wrinkles, and sun-protected areas. Br J Dermatol. 1999;140:1038–47. doi:10.1046/j.1365-2133.1999.02901.x. [PubMed] [CrossRef] [Google Scholar]
24. Varani J, Spearman D, Perone P, Fligiel SE, Datta SC, Wang ZQ, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol. 2001;158:931–42. doi:10.1016/S0002-9440(10)64040-0. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
25. Brenneisen P, Oh J, Wlaschek M, Wenk J, Briviba K, Hommel C, et al. Ultraviolet B wavelength dependence for the regulation of two major matrix-metalloproteinases and their inhibitor TIMP-1 in human dermal fibroblasts. Photochem Photobiol. 1996;64:877–85. doi:10.1111/j.1751-1097.1996.tb01851.x. [PubMed] [CrossRef] [Google Scholar]
26. Fisher GJ, Datta SC, Talwar HS, Wang ZQ, Varani J, Kang S, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379:335–9. doi:10.1038/379335a0. [PubMed] [CrossRef] [Google Scholar]
27. Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997;337:1419–28. doi:10.1056/NEJM199711133372003. [PubMed] [CrossRef] [Google Scholar]
28. Scharffetter-Kochanek K, Wlaschek M, Briviba K, Sies H. Singlet oxygen induces collagenase expression in human skin fibroblasts. FEBS Lett. 1993;331:304–6. doi:10.1016/0014-5793(93)80357-Z. [PubMed] [CrossRef] [Google Scholar]
29. Oikarinen A. The aging of skin: chronoaging versus photoaging. Photodermatol Photoimmunol Photomed. 1990;7:3–4. [PubMed] [Google Scholar]
30. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93:639–43. doi:10.1111/j.1365-2133.1975.tb05113.x. [PubMed] [CrossRef] [Google Scholar]
31. Bernstein EF, Underhill CB, Hahn PJ, Brown DB, Uitto J. Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans. Br J Dermatol. 1996;135:255–62. doi:10.1111/j.1365-2133.1996.tb01156.x. [PubMed] [CrossRef] [Google Scholar]
32. Elsner P, Maibach HI. Cosmeceuticals and Active Cosmetics: Drugs versus Cosmetics (2nd edn). Marcel Dekker: New York, 2005. [Google Scholar]
33. Calasanti TM, Slevin KF, King N. Ageism and feminism: from ‘et cetera’ to center. NWSA J. 2006;18:13–30. doi:10.2979/NWS.2006.18.1.13. [CrossRef] [Google Scholar]
34. Bayer K. Cosmetic surgery and cosmetics: redefining the appearance of age. Generations. 2005:13–8. [Google Scholar]
35. Holstein MB, Minkler M. Self, society, and the “new gerontology” Gerontologist. 2003;43:787–96. doi:10.1093/geront/43.6.787. [PubMed] [CrossRef] [Google Scholar]
36. Mykytyn C. Anti-aging medicine: Predictions, moral obligations, and biomedical intervention. Anthropol Q. 2006;79:5–32. doi:10.1353/anq.2006.0010. [CrossRef] [Google Scholar]
37. Wollina U, Payne CR. Aging well--the role of minimally invasive aesthetic dermatological procedures in women over 65. J Cosmet Dermatol. 2010;9:50–8. doi:10.1111/j.1473-2165.2010.00475.x. [PubMed] [CrossRef] [Google Scholar]
38. Vedamurthy M. Antiaging therapies. Indian J Dermatol Venereol Leprol. 2006;72:183–6. [PubMed] [Google Scholar]
39. Dierickx CC, Anderson RR. Visible light treatment of photoaging. Dermatol Ther. 2005;18:191–208. doi:10.1111/j.1529-8019.2005.05019.x. [PubMed] [CrossRef] [Google Scholar]
40. Tabata N, O’Goshi K, Zhen YX, Kligman AM, Tagami H. Biophysical assessment of persistent effects of moisturizers after their daily applications: evaluation of corneotherapy. Dermatology. 2000;200:308–13. doi:10.1159/000018393. [PubMed] [CrossRef] [Google Scholar]
41. Lübbe J. Evidence-based corneotherapy. Dermatology. 2000;200:285–9. doi:10.1159/000018388. [PubMed] [CrossRef] [Google Scholar]
42. Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung JH, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114:480–6. doi:10.1046/j.1523-1747.2000.00902.x. [PubMed] [CrossRef] [Google Scholar]
43. Nusgens BV, Humbert P, Rougier A, Colige AC, Haftek M, Lambert CA, et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol. 2001;116:853–9. doi:10.1046/j.0022-202x.2001.01362.x. [PubMed] [CrossRef] [Google Scholar]
44. Kockaert M, Neumann M. Systemic and topical drugs for aging skin. J Drugs Dermatol. 2003;2:435–41. [PubMed] [Google Scholar]
45. Margelin D, Medaisko C, Lombard D, Picard J, Fourtanier A. Hyaluronic acid and dermatan sulfate are selectively stimulated by retinoic acid in irradiated and nonirradiated hairless mouse skin. J Invest Dermatol. 1996;106:505–9. doi:10.1111/1523-1747.ep12343819. [PubMed] [CrossRef] [Google Scholar]
46. Trautinger F. Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clin Exp Dermatol. 2001;26:573–7. doi:10.1046/j.1365-2230.2001.00893.x. [PubMed] [CrossRef] [Google Scholar]
47. Berger MM. Can oxidative damage be treated nutritionally? Clin Nutr. 2005;24:172–83. doi:10.1016/j.clnu.2004.10.003. [PubMed] [CrossRef] [Google Scholar]
48. Marini A. [Beauty from the inside. Does it really work?] Hautarzt. 2011;62:614–7. doi:10.1007/s00105-011-2138-5. [PubMed] [CrossRef] [Google Scholar]
49. Fusco D, Colloca G, Lo Monaco MR, Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interv Aging. 2007;2:377–87. [PMC free article] [PubMed] [Google Scholar]
50. Terada A, Yoshida M, Seko Y, Kobayashi T, Yoshida K, Nakada M, et al. Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds. Nutrition. 1999;15:651–5. doi:10.1016/S0899-9007(99)00119-7. [PubMed] [CrossRef] [Google Scholar]
51. Lin FH, Lin JY, Gupta RD, Tournas JA, Burch JA, Selim MA, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol. 2005;125:826–32. doi:10.1111/j.0022-202X.2005.23768.x. [PubMed] [CrossRef] [Google Scholar]
52. Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26:231–8. doi:10.1111/j.1467-2494.2004.00228.x. [PubMed] [CrossRef] [Google Scholar]
53. Haftek M, Mac-Mary S, Le Bitoux MA, Creidi P, Seité S, Rougier A, et al. Clinical, biometric and structural evaluation of the long-term effects of a topical treatment with ascorbic acid and madecassoside in photoaged human skin. Exp Dermatol. 2008;17:946–52. doi:10.1111/j.1600-0625.2008.00732.x. [PubMed] [CrossRef] [Google Scholar]
54. Kerscher M, Buntrock H. [Anti-aging creams. What really helps?] Hautarzt. 2011;62:607–13. doi:10.1007/s00105-011-2137-6. [PubMed] [CrossRef] [Google Scholar]
55. Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. J Am Acad Dermatol. 2008;59:418–25. doi:10.1016/j.jaad.2008.05.004. [PubMed] [CrossRef] [Google Scholar]
56. Draelos ZD. The latest cosmeceutical approaches for anti-aging. J Cosmet Dermatol. 2007;6:2–6. doi:10.1111/j.1473-2165.2007.00313.x. [PubMed] [CrossRef] [Google Scholar]
57. Zhai H, Behnam S, Villarama CD, Arens-Corell M, Choi MJ, Maibach HI. Evaluation of the antioxidant capacity and preventive effects of a topical emulsion and its vehicle control on the skin response to UV exposure. Skin Pharmacol Physiol. 2005;18:288–93. doi:10.1159/000088014. [PubMed] [CrossRef] [Google Scholar]
58. Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol. 2001;44:425–32. doi:10.1067/mjd.2001.112919. [PubMed] [CrossRef] [Google Scholar]
59. Kafi R, Kwak HS, Schumacher WE, Cho S, Hanft VN, Hamilton TA, et al. Improvement of naturally aged skin with vitamin A (retinol) Arch Dermatol. 2007;143:606–12. doi:10.1001/archderm.143.5.606. [PubMed] [CrossRef] [Google Scholar]
60. Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung JH, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114:480–6. doi:10.1046/j.1523-1747.2000.00902.x. [PubMed] [CrossRef] [Google Scholar]
61. Bhawan J. Short- and long-term histologic effects of topical tretinoin on photodamaged skin. Int J Dermatol. 1998;37:286–92. doi:10.1046/j.1365-4362.1998.00433.x. [PubMed] [CrossRef] [Google Scholar]
62. Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20:343–9. doi:10.1111/j.1529-8019.2007.00148.x. [PubMed] [CrossRef] [Google Scholar]
63. Nelson BR, Majmudar G, Griffiths CE, Gillard MO, Dixon AE, Tavakkol A, et al. Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. Arch Dermatol. 1994;130:1136–42. doi:10.1001/archderm.1994.01690090060008. [PubMed] [CrossRef] [Google Scholar]
64. Ostler EL, Wallis CV, Aboalchamat B, Faragher RG. Telomerase and the cellular lifespan: implications of the aging process. J Pediatr Endocrinol Metab. 2000;13(Suppl 6):1467–76. [PubMed] [Google Scholar]
65. Monheit GD, Chastain MA. Chemical peels. Facial Plast Surg Clin North Am. 2001;9:239–55, viii. [PubMed] [Google Scholar]
66. Fischer TC, Perosino E, Poli F, Viera MS, Dreno B, Cosmetic Dermatology European Expert Group Chemical peels in aesthetic dermatology: an update 2009. J Eur Acad Dermatol Venereol. 2010;24:281–92. doi:10.1111/j.1468-3083.2009.03409.x. [PubMed] [CrossRef] [Google Scholar]
67. Brown AM, Kaplan LM, Brown ME. Phenol-induced histological skin changes: hazards, technique, and uses. Br J Plast Surg. 1960;13:158–69. doi:10.1016/S0007-1226(60)80032-X. [PubMed] [CrossRef] [Google Scholar]
68. Fartasch M, Teal J, Menon GK. Mode of action of glycolic acid on human stratum corneum: ultrastructural and functional evaluation of the epidermal barrier. Arch Dermatol Res. 1997;289:404–9. doi:10.1007/s004030050212. [PubMed] [CrossRef] [Google Scholar]
69. Deprez P. Textbook of Chemical Peels. Superficial, Medium, and Deep Peels in Cosmetic Practice. Informa UK, London, 2007. [Google Scholar]
70. Baker TJ, Gordon HL. The ablation of rhytides by chemical means; a preliminary report. J Fla Med Assoc. 1961;48:541. [PubMed] [Google Scholar]
71. Behin F, Feuerstein SS, Marovitz WF. Comparative histological study of mini pig skin after chemical peel in an animal model after chemical peel and dermabrasion. Arch Otolaryngol. 1977;103:271. doi:10.1001/archotol.1977.00780220065006. [PubMed] [CrossRef] [Google Scholar]
72. Vagotis FL, Brundage SR. Histologic study of dermabrasion and chemical peel in an animal model after pretreatment with Retin-A. Aesthetic Plast Surg. 1995;19:243–6. doi:10.1007/BF00451097. [PubMed] [CrossRef] [Google Scholar]
73. Han SH, Kim HJ, Kim SY, Kim YC, Choi GS, Shin JH. Effects of chemical peeling in photoaged hairless mice. Int J Dermatol. 2011;50:1075–82. doi:10.1111/j.1365-4632.2010.04712.x. [PubMed] [CrossRef] [Google Scholar]
74. Butler PE, Gonzalez S, Randolph MA, Kim J, Kollias N, Yaremchuk MJ. Quantitative and qualitative effects of chemical peeling on photo-aged skin: an experimental study. Plast Reconstr Surg. 2001;107:222–8. doi:10.1097/00006534-200101000-00036. [PubMed] [CrossRef] [Google Scholar]
75. Nelson BR, Fader DJ, Gillard M, Majmudar G, Johnson TM. Pilot histologic and ultrastructural study of the effects of medium-depth chemical facial peels on dermal collagen in patients with actinically damaged skin. J Am Acad Dermatol. 1995;32:472–8. doi:10.1016/0190-9622(95)90072-1. [PubMed] [CrossRef] [Google Scholar]
76. El-Domyati MB, Attia SK, Saleh FY, Ahmad HM, Uitto JJ. Trichloroacetic acid peeling versus dermabrasion: a histometric, immunohistochemical, and ultrastructural comparison. Dermatol Surg. 2004;30:179–88. doi:10.1111/j.1524-4725.2004.30061.x. [PubMed] [CrossRef] [Google Scholar]
77. Sadick NS. Update on non-ablative light therapy for rejuvenation: a review. Lasers Surg Med. 2003;32:120–8. doi:10.1002/lsm.10127. [PubMed] [CrossRef] [Google Scholar]
78. Hardaway CA, Ross EV. Nonablative laser skin remodeling. Dermatol Clin. 2002;20:97–111, ix. doi:10.1016/S0733-8635(03)00049-4. [PubMed] [CrossRef] [Google Scholar]
79. Bjerring P, Christiansen K, Troilius A, Dierickx C. Facial photo rejuvenation using two different intense pulsed light (IPL) wavelength bands. Lasers Surg Med. 2004;34:120–6. doi:10.1002/lsm.20000. [PubMed] [CrossRef] [Google Scholar]
80. Goldberg DJ. Full-face nonablative dermal remodeling with a 1320 nm Nd:YAG laser. Dermatol Surg. 2000;26:915–8. doi:10.1046/j.1524-4725.2000.026010915.x. [PubMed] [CrossRef] [Google Scholar]
81. Goldberg DJ, Rogachefsky AS, Silapunt S. Non-ablative laser treatment of facial rhytides: a comparison of 1450-nm diode laser treatment with dynamic cooling as opposed to treatment with dynamic cooling alone. Lasers Surg Med. 2002;30:79–81. doi:10.1002/lsm.10011. [PubMed] [CrossRef] [Google Scholar]
82. Fournier N, Dahan S, Barneon G, Rouvrais C, Diridollou S, Lagarde JM, et al. Nonablative remodeling: a 14-month clinical ultrasound imaging and profilometric evaluation of a 1540 nm Er:Glass laser. Dermatol Surg. 2002;28:926–31. doi:10.1046/j.1524-4725.2002.02078.x. [PubMed] [CrossRef] [Google Scholar]
83. Bjerring P, Clement M, Heickendorff L, Egevist H, Kiernan M. Selective non-ablative wrinkle reduction by laser. J Cutan Laser Ther. 2000;2:9–15. [PubMed] [Google Scholar]
84. Zelickson BD, Kilmer SL, Bernstein E, Chotzen VA, Dock J, Mehregan D, et al. Pulsed dye laser therapy for sun damaged skin. Lasers Surg Med. 1999;25:229–36. doi:10.1002/(SICI)1096-9101(1999)25:3<229::AID-LSM7>3.0.CO;2-D. [PubMed] [CrossRef] [Google Scholar]
85. Goldberg D, Tan M, Dale Sarradet M, Gordon M. Nonablative dermal remodeling with a 585-nm, 350-microsec, flashlamp pulsed dye laser: clinical and ultrastructural analysis. Dermatol Surg. 2003;29:161–3, discussion 163-4. doi:10.1046/j.1524-4725.2003.29040.x. [PubMed] [CrossRef] [Google Scholar]
86. Prieto VG, Sadick NS, Lloreta J, Nicholson J, Shea CR. Effects of intense pulsed light on sun-damaged human skin, routine, and ultrastructural analysis. Lasers Surg Med. 2002;30:82–5. doi:10.1002/lsm.10042. [PubMed] [CrossRef] [Google Scholar]
87. Tanghetti E, Sherr E. Treatment of telangiectasia using the multi-pass technique with the extended pulse width, pulsed dye laser (Cynosure V-Star) J Cosmet Laser Ther. 2003;5:71–5. doi:10.1080/14769170310001249. [PubMed] [CrossRef] [Google Scholar]
88. Alam M, Dover JS, Arndt KA. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg. 2003;29:681–4, discussion 685. doi:10.1046/j.1524-4725.2003.29181.x. [PubMed] [CrossRef] [Google Scholar]
89. Negishi K, Wakamatsu S, Kushikata N, Tezuka Y, Kotani Y, Shiba K. Full-face photorejuvenation of photodamaged skin by intense pulsed light with integrated contact cooling: initial experiences in Asian patients. Lasers Surg Med. 2002;30:298–305. doi:10.1002/lsm.10036. [PubMed] [CrossRef] [Google Scholar]
90. Negishi K, Tezuka Y, Kushikata N, Wakamatsu S. Photorejuvenation for Asian skin by intense pulsed light. Dermatol Surg. 2001;27:627–31, discussion 632. doi:10.1046/j.1524-4725.2001.01002.x. [PubMed] [CrossRef] [Google Scholar]
91. Omi T, Kawana S, Sato S, Honda M. Ultrastructural changes elicited by a non-ablative wrinkle reduction laser. Lasers Surg Med. 2003;32:46–9. doi:10.1002/lsm.10119. [PubMed] [CrossRef] [Google Scholar]
92. Zelickson B, Kist D. Effect of pulsed dye laser and intense pulse light source in dermal extracellular matrix remodeling. Lasers Surg Med. 2000;S12:68. [Google Scholar]
93. Hsu TS, Zelickson B, Dover JS, Kilmer S, Burns J, Hruza G, et al. Multicenter study of the safety and efficacy of a 585 nm pulsed-dye laser for the nonablative treatment of facial rhytides. Dermatol Surg. 2005;31:1–9. [PubMed] [Google Scholar]
94. Moody BR, McCarthy JE, Hruza GJ. Collagen remodeling after 585-nm pulsed dye laser irradiation: an ultrasonographic analysis. Dermatol Surg. 2003;29:997–9, discussion 999-1000. doi:10.1046/j.1524-4725.2003.29290.x. [PubMed] [CrossRef] [Google Scholar]
95. Bjerring P, Clement M, Heickendorff L, Lybecker H, Kiernan M. Dermal collagen production following irradiation by dye laser and broadband light source. J Cosmet Laser Ther. 2002;4:39–43. doi:10.1080/147641702320602555. [PubMed] [CrossRef] [Google Scholar]
96. Dahiya R, Lam SM, Williams EF., 3rd A systematic histologic analysis of nonablative laser therapy in a porcine model using the pulsed dye laser. Arch Facial Plast Surg. 2003;5:218–23. doi:10.1001/archfaci.5.3.218. [PubMed] [CrossRef] [Google Scholar]
97. Goldberg DJ, Cutler KB. Nonablative treatment of rhytids with intense pulsed light. Lasers Surg Med. 2000;26:196–200. doi:10.1002/(SICI)1096-9101(2000)26:2<196::AID-LSM10>3.0.CO;2-9. [PubMed] [CrossRef] [Google Scholar]
98. Goldberg DJ. New collagen formation after dermal remodeling with an intense pulsed light source. J Cutan Laser Ther. 2000;2:59–61. [PubMed] [Google Scholar]
99. Hernández-Pérez E, Ibiett EV. Gross and microscopic findings in patients submitted to nonablative full-face resurfacing using intense pulsed light: a preliminary study. Dermatol Surg. 2002;28:651–5. doi:10.1046/j.1524-4725.2002.02010.x. [PubMed] [CrossRef] [Google Scholar]
100. Alster TS, Garg S. Treatment of facial rhytides with a high-energy pulsed carbon dioxide laser. Plast Reconstr Surg. 1996;98:791–4. doi:10.1097/00006534-199610000-00005. [PubMed] [CrossRef] [Google Scholar]
101. Lowe NJ, Lask G, Griffin ME, Maxwell A, Lowe P, Quilada F. Skin resurfacing with the Ultrapulse carbon dioxide laser. Observations on 100 patients. Dermatol Surg. 1995;21:1025–9. doi:10.1016/1076-0512(96)82352-1. [PubMed] [CrossRef] [Google Scholar]
102. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol. 1996;132:395–402. doi:10.1001/archderm.1996.03890280047007. [PubMed] [CrossRef] [Google Scholar]
103. Teikemeier G, Goldberg DJ. Skin resurfacing with the erbium:YAG laser. Dermatol Surg. 1997;23:685–7. doi:10.1016/S1076-0512(97)00179-9. [PubMed] [CrossRef] [Google Scholar]
104. Biesman BS. Fractional ablative skin resurfacing: complications. Lasers Surg Med. 2009;41:177–8. doi:10.1002/lsm.20764. [PubMed] [CrossRef] [Google Scholar]
105. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34:426–38. doi:10.1002/lsm.20048. [PubMed] [CrossRef] [Google Scholar]
106. Farkas JP, Richardson JA, Hoopman J, Brown SA, Kenkel JM. Micro-island damage with a nonablative 1540-nm Er:Glass fractional laser device in human skin. J Cosmet Dermatol. 2009;8:119–26. doi:10.1111/j.1473-2165.2009.00441.x. [PubMed] [CrossRef] [Google Scholar]
107. Laubach HJ, Tannous Z, Anderson RR, Manstein D. Skin responses to fractional photothermolysis. Lasers Surg Med. 2006;38:142–9. doi:10.1002/lsm.20254. [PubMed] [CrossRef] [Google Scholar]
108. Helbig D, Paasch U. Molecular changes during skin aging and wound healing after fractional ablative photothermolysis. Skin Res Technol. 2011;17:119–28. doi:10.1111/j.1600-0846.2010.00477.x. [PubMed] [CrossRef] [Google Scholar]
109. Hantash BM, Bedi VP, Kapadia B, Rahman Z, Jiang K, Tanner H, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39:96–107. doi:10.1002/lsm.20468. [PubMed] [CrossRef] [Google Scholar]
110. Arany PR, Nayak RS, Hallikerimath S, Limaye AM, Kale AD, Kondaiah P. Activation of latent TGF-beta1 by low-power laser in vitro correlates with increased TGF-beta1 levels in laser-enhanced oral wound healing. Wound Repair Regen. 2007;15:866–74. doi:10.1111/j.1524-475X.2007.00306.x. [PubMed] [CrossRef] [Google Scholar]
111. Souil E, Capon A, Mordon S, Dinh-Xuan AT, Polla BS, Bachelet M. Treatment with 815-nm diode laser induces long-lasting expression of 72-kDa heat shock protein in normal rat skin. Br J Dermatol. 2001;144:260–6. doi:10.1046/j.1365-2133.2001.04010.x. [PubMed] [CrossRef] [Google Scholar]
112. Wilmink GJ, Opalenik SR, Beckham JT, Abraham AA, Nanney LB, Mahadevan-Jansen A, et al. Molecular imaging-assisted optimization of hsp70 expression during laser-induced thermal preconditioning for wound repair enhancement. J Invest Dermatol. 2009;129:205–16. doi:10.1038/jid.2008.175. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
113. Ravanti L, Kähäri VM. Matrix metalloproteinases in wound repair (review) Int J Mol Med. 2000;6:391–407. [PubMed] [Google Scholar]
114. Orringer JS, Kang S, Johnson TM, Karimipour DJ, Hamilton T, Hammerberg C, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol. 2004;140:1326–32. doi:10.1001/archderm.140.11.1326. [PubMed] [CrossRef] [Google Scholar]
115. Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32:78–87. doi:10.1002/lsm.10145. [PubMed] [CrossRef] [Google Scholar]
116. Iorizzo M, De Padova MP, Tosti A. Biorejuvenation: theory and practice. Clin Dermatol. 2008;26:177–81. doi:10.1016/j.clindermatol.2007.09.011. [PubMed] [CrossRef] [Google Scholar]
117. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg. 2006;32:465–80. doi:10.1111/j.1524-4725.2006.32100.x. [PubMed] [CrossRef] [Google Scholar]
118. Caruso MK, Roberts AT, Bissoon L, Self KS, Guillot TS, Greenway FL. An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite. J Plast Reconstr Aesthet Surg. 2008;61:1321–4. doi:10.1016/j.bjps.2007.03.039. [PubMed] [CrossRef] [Google Scholar]
119. Matarasso A, Pfeifer TM, Plastic Surgery Educational Foundation DATA Committee Mesotherapy for body contouring. Plast Reconstr Surg. 2005;115:1420–4. doi:10.1097/01.PRS.0000162227.94032.ED. [PubMed] [CrossRef] [Google Scholar]
120. Rotunda AM, Avram MM, Avram AS. Cellulite: Is there a role for injectables? J Cosmet Laser Ther. 2005;7:147–54. doi:10.1080/14764170500430234. [PubMed] [CrossRef] [Google Scholar]
121. Lacarrubba F, Tedeschi A, Nardone B, Micali G. Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatol Ther. 2008;21(Suppl 3):S1–5. doi:10.1111/j.1529-8019.2008.00234.x. [PubMed] [CrossRef] [Google Scholar]
122. Jager C, Brenner C, Habicht J, Wallic R. Bioactive reagents used in mesotherapy for skin rejuvenation in vivo induce diverse physiological processes in human skin fibroblasts in vitro – a pilot study. Exp Dermatol. 2011;21:70–80. [PubMed] [Google Scholar]
123. Amin SP, Phelps RG, Goldberg DJ. Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg. 2006;32:1467–72. doi:10.1111/j.1524-4725.2006.32353.x. [PubMed] [CrossRef] [Google Scholar]
124. Atiyeh BS, Ibrahim AE, Dibo SA. Aesthetic Plast Surg 2008: 32: 842–849. 12 Brown S A. Aesthet Surg J. 2006;26:95–8. [PubMed] [Google Scholar]
125. Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg. 2006;118:98e–106e. doi:10.1097/01.prs.0000232436.91409.30. [PubMed] [CrossRef] [Google Scholar]
126. Haneke E. Skin rejuvenation without a scalpel. I. Fillers. J Cosmet Dermatol. 2006;5:157–67. doi:10.1111/j.1473-2165.2006.00243.x. [PubMed] [CrossRef] [Google Scholar]
127. Homicz MR, Watson D. Review of injectable materials for soft tissue augmentation. Facial Plast Surg. 2004;20:21–9. doi:10.1055/s-2004-822955. [PubMed] [CrossRef] [Google Scholar]
128. Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation: a clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg. 2005;55:30–5, discussion 35. doi:10.1097/01.sap.0000168292.69753.73. [PubMed] [CrossRef] [Google Scholar]
129. Klein AW. Techniques for soft tissue augmentation: an ‘a to z’ Am J Clin Dermatol. 2006;7:107–20. doi:10.2165/00128071-200607020-00004. [PubMed] [CrossRef] [Google Scholar]
130. Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6:2397–404. [PubMed] [Google Scholar]
131. Tzellos TG, Klagas I, Vahtsevanos K, Triaridis S, Printza A, Kyrgidis A, et al. Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol. 2009;18:1028–35. doi:10.1111/j.1600-0625.2009.00889.x. [PubMed] [CrossRef] [Google Scholar]
132. Alberts B, Johnson A, Lewis J, et al., eds. 2002. The molecular biology of the cell. Cell junctions, cell adhesion, and the extracellular matrix. 1065. New York: Garland Science. [Google Scholar]
133. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol. 1994;6:726–33. doi:10.1016/0955-0674(94)90100-7. [PubMed] [CrossRef] [Google Scholar]
134. Turley EA. Hyaluronan and cell locomotion. Cancer Metastasis Rev. 1992;11:21–30. doi:10.1007/BF00047600. [PubMed] [CrossRef] [Google Scholar]
135. Papakonstantinou E, Karakiulakis G, Eickelberg O, Perruchoud AP, Block L-H, Roth M. A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology. 1998;8:821–30. doi:10.1093/glycob/8.8.821. [PubMed] [CrossRef] [Google Scholar]
136. Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem. 2002;277:4581–4. doi:10.1074/jbc.R100037200. [PubMed] [CrossRef] [Google Scholar]
137. Fligiel SE, Varani J, Datta SC, Kang S, Fisher GJ, Voorhees JJ. Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol. 2003;120:842–8. doi:10.1046/j.1523-1747.2003.12148.x. [PubMed] [CrossRef] [Google Scholar]
138. Kuroda K, Shinkai H. Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res. 1997;289:567–72. doi:10.1007/s004030050241. [PubMed] [CrossRef] [Google Scholar]
139. Uitto J, Bernstein EF. Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis. J Investig Dermatol Symp Proc. 1998;3:41–4. [PubMed] [Google Scholar]
140. Yoneda M, Shimizu S, Nishi Y, Yamagata M, Suzuki S, Kimata K. Hyaluronic acid-dependent change in the extracellular matrix of mouse dermal fibroblasts that is conducive to cell proliferation. J Cell Sci. 1988;90:275–86. [PubMed] [Google Scholar]
141. Gao F, Liu Y, He Y, Yang C, Wang Y, Shi X, et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol. 2010;29:107–16. doi:10.1016/j.matbio.2009.11.002. [PubMed] [CrossRef] [Google Scholar]
142. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol. 2007;23:435–61. doi:10.1146/annurev.cellbio.23.090506.123337. [PubMed] [CrossRef] [Google Scholar]
143. Fink RM, Lengfelder E. Hyaluronic acid degradation by ascorbic acid and influence of iron. Free Radic Res Commun. 1987;3:85–92. doi:10.3109/10715768709069773. [PubMed] [CrossRef] [Google Scholar]
144. Carruthers A, Carruthers J. Non-animal-based hyaluronic acid fillers: scientific and technical considerations. Plast Reconstr Surg. 2007;120(Suppl):33S–40S. doi:10.1097/01.prs.0000248808.75700.5f. [PubMed] [CrossRef] [Google Scholar]
145. Balazs EA, Bland PA, Denlinger JL, Goldman AI, Larsen NE, Leshchiner EA, et al. Matrix engineering. Blood Coagul Fibrinolysis. 1991;2:173–8. doi:10.1097/00001721-199102000-00026. [PubMed] [CrossRef] [Google Scholar]
146. Andre P. New trends in face rejuvenation by hyaluronic acid injections. J Cosmet Dermatol. 2008;7:251–8. doi:10.1111/j.1473-2165.2008.00402.x. [PubMed] [CrossRef] [Google Scholar]
147. Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg. 2006;118:98e–106e. doi:10.1097/01.prs.0000232436.91409.30. [PubMed] [CrossRef] [Google Scholar]
148. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2:369–76. [PMC free article] [PubMed] [Google Scholar]
149. Robinson JK, Hanke CW, Sengelmann RD, Siegel DM. Surgery of the skin. Philadelphia: Elsevier Mosby, 2005. [Google Scholar]
150. Alam M, Gladstone H, Kramer EM, Murphy JP, Jr., Nouri K, Neuhaus IM, et al.American Society for Dermatologic Surgery ASDS guidelines of care: injectable fillers. Dermatol Surg. 2008;34(Suppl 1):S115–48. doi:10.1111/j.1524-4725.2008.34253.x. [PubMed] [CrossRef] [Google Scholar]
151. Lizzul PF, Narurkar VA. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation. J Drugs Dermatol. 2010;9:446–50. [PubMed] [Google Scholar]
152. Goldberg DJ. Breakthroughs in US dermal fillers for facial soft-tissue augmentation. J Cosmet Laser Ther. 2009;11:240–7. doi:10.3109/14764170903341731. [PubMed] [CrossRef] [Google Scholar]
153. Ghersetich I, Lotti T, Campanile G, Grappone C, Dini G. Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol. 1994;33:119–22. doi:10.1111/j.1365-4362.1994.tb01540.x. [PubMed] [CrossRef] [Google Scholar]
154. Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg. 2007;120(Suppl):55S–66S. doi:10.1097/01.prs.0000285109.34527.b9. [PubMed] [CrossRef] [Google Scholar]
155. Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008;34(Suppl 1):S9–15. doi:10.1111/j.1524-4725.2008.34237.x. [PubMed] [CrossRef] [Google Scholar]
156. Burgess CM, Lowe NJ. NewFill for skin augmentation: a new filler or failure? Dermatol Surg. 2006;32:1530–2, author reply 1532. doi:10.1111/j.1524-4725.2006.32369.x. [PubMed] [CrossRef] [Google Scholar]
157. Mest D. Experience with injectable poly-L-lactic acid in clinicalpractice. Cosmetic Dermatol. 2005;18:5–8. [Google Scholar]
158. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52:233–9. doi:10.1016/j.jaad.2004.08.056. [PubMed] [CrossRef] [Google Scholar]
159. Sturm LP, Cooter RD, Mutimer KL, Graham JC, Maddern GJ. A systematic review of dermal fillers for age-related lines and wrinkles. ANZ J Surg. 2011;81:9–17. doi:10.1111/j.1445-2197.2010.05351.x. [PubMed] [CrossRef] [Google Scholar]
160. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion. 2001;41:1217–24. doi:10.1046/j.1537-2995.2001.41101217.x. [PubMed] [CrossRef] [Google Scholar]
161. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489–96. doi:10.1016/j.joms.2003.12.003. [PubMed] [CrossRef] [Google Scholar]
162. Freymiller EG. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:1046–, author reply 1047-8. doi:10.1016/j.joms.2004.05.205. [PubMed] [CrossRef] [Google Scholar]
163. Wrotniak M, Bielecki T, Gaździk TS. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil. 2007;9:227–38. [PubMed] [Google Scholar]
164. Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, et al. Can Platelet-rich Plasma Be Used for Skin Rejuvenation? Evaluation of Effects of Platelet-rich Plasma on Human Dermal Fibroblast. Ann Dermatol. 2011;23:424–31. [PMC free article] [PubMed] [Google Scholar]
165. Krasna M, Domanovic D, Tomsic A, Svajger U, Jeras M. Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta Dermatovenerol Alp Panonica Adriat. 2007;16:105–10. [PubMed] [Google Scholar]
166. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials. 2003;24:3095–100. doi:10.1016/S0142-9612(03)00114-5. [PubMed] [CrossRef] [Google Scholar]
167. Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T. Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. J Oral Maxillofac Surg. 2005;63:362–9. doi:10.1016/j.joms.2004.07.016. [PubMed] [CrossRef] [Google Scholar]
168. Dessy LA, Mazzocchi M, Rubino C, Mazzarello V, Spissu N, Scuderi N. An objective assessment of botulinum toxin A effect on superficial skin texture. Ann Plast Surg. 2007;58:469–73. doi:10.1097/01.sap.0000244968.16977.1f. [PubMed] [CrossRef] [Google Scholar]
169. Cheng CM. Cosmetic use of botulinum toxin type A in the elderly. Clin Interv Aging. 2007;2:81–3. doi:10.2147/ciia.2007.2.1.81. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
170. Rzany B, Dill-Müller D, Grablowitz D, Heckmann M, Caird D, German-Austrian Retrospective Study Group Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. Dermatol Surg. 2007;33(1 Spec No.):S18–25. doi:10.1111/j.1524-4725.2006.32327.x. [PubMed] [CrossRef] [Google Scholar]
171. Böni R, Kreyden OP, Burg G. Revival of the use of botulinum toxin: application in dermatology. Dermatology. 2000;200:287–91. doi:10.1159/000018389. [PubMed] [CrossRef] [Google Scholar]
172. Coffield JA, Considine RB, Simpson LL. The site and mechanism of action of botulinum neurotoxin; in Jankovic J, Hallett M (eds): Therapy with Botulinum Toxin. New York, Dekker, 1994, pp 3–14. [Google Scholar]
173. Coleman WP, Hanke CW, Alt TH. Cosmetic Surgery of the Skin, 2nd edn. St Louis, Missouri: Mosby Year Book Inc., 1997: 231-235. [Google Scholar]
174. Garcia A, Fulton JE., Jr. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study. Dermatol Surg. 1996;22:39–43. doi:10.1016/1076-0512(95)00464-5. [PubMed] [CrossRef] [Google Scholar]
175. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol. 1996;34:788–97. doi:10.1016/S0190-9622(96)90016-X. [PubMed] [CrossRef] [Google Scholar]
176. Guyuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg. 1994;93:913–8. doi:10.1097/00006534-199404001-00003. [PubMed] [CrossRef] [Google Scholar]
177. Brooks GF, Butel JS, Ornston LN. Jawetz, Melnick and Adelbergs Medical Microbiology, 20th edn. Connecticut: Appleton and Lange, 1995: 174±176. [Google Scholar]
178. Aoki RK. Immunologic and other properties of therapeutic botulinum toxin serotypes. In: BrinMF, Hallett M, Jankovic J, eds. Scientific and Therapeutic Aspects of Botulinum Toxin. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. [Google Scholar]
179. Becker-Wegerich P, Rauch L, Ruzicka T. Botulinum toxin A in the therapy of mimic facial lines. Clin Exp Dermatol. 2001;26:619–30. doi:10.1046/j.1365-2230.2001.00901.x. [PubMed] [CrossRef] [Google Scholar]
180. Ganong WF. Review of Medical Physiology, 16th edn. East Norwalk, Connecticut: Appleton and Lange, 1993: 99±102. [Google Scholar]
181. de Paiva A, Meunier FA, Molgó J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A. 1999;96:3200–5. doi:10.1073/pnas.96.6.3200. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
182. Product Information Package Insert. (71390US12J). Irvine, CA: Allergan, Inc.; 2002. [Google Scholar]
183. Hatheway CG. Immunology of Botulinum Toxin. New York: Marcel-Dekker; 1993. [Google Scholar]
184. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43:249–59. doi:10.1067/mjd.2000.105567. [PubMed] [CrossRef] [Google Scholar]
185. Rzany B, Ascher B, Monheit GD. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. J Eur Acad Dermatol Venereol. 2010;24(Suppl 1):1–14. doi:10.1111/j.1468-3083.2009.03475.x. [PubMed] [CrossRef] [Google Scholar]
186. Botox (Package Insert). Allergan, Inc.
187. Carruthers J, fa*gien S, Matarasso SL. the Botox Consensus Group. Botulinum toxin and facial aesthetics. Plast Reconstr Surg. 2004;114:1S–22S. doi:10.1097/01.PRS.0000144795.76040.D3. [PubMed] [CrossRef] [Google Scholar]
188. Shetty MK, IADVL Dermatosurgery Task Force Guidelines on the use of botulinum toxin type A. Indian J Dermatol Venereol Leprol. 2008;74(Suppl):S13–22. [PubMed] [Google Scholar]
189. Sommer B, Sattler G. Botulinumtoxin in der aÈsthetischen Medizin. Berlin; Blackwell Vissenschafts-Verlag, 2001. [Google Scholar]
190. Carruthers J, Carruthers A. Cosmetic use of botulinum A exotoxin. In: Advances in Dermatology (Dzubow L, ed.) 1996: 280-303. [PubMed] [Google Scholar]
191. Lange DJ, Rubin M, Greene PE, Kang UJ, Moskowitz CB, Brin MF, et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve. 1991;14:672–5. doi:10.1002/mus.880140711. [PubMed] [CrossRef] [Google Scholar]
192. Goschel H, et al. Botulinum toxin therapy, neutralizing and non-neutralizing antibodies. Exp Neurol. 1997;147:96. doi:10.1006/exnr.1997.6580. [PubMed] [CrossRef] [Google Scholar]
193. Blitzer A, Binder WJ, Boyd JB, Carruthers A. Management of Facial Lines and Wrinkles. Philadelphia, PA: Lippincott Williams & Wilkins; 2000. [Google Scholar]
194. Matarasso A, Deva AK, American Society of Plastic Surgeons DATA Committee Botulinum toxin. Plast Reconstr Surg. 2002;109:1191–7. doi:10.1097/00006534-200203000-00066. [PubMed] [CrossRef] [Google Scholar]
195. fa*gien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg. 1999;103:701–13. doi:10.1097/00006534-199902000-00055. [PubMed] [CrossRef] [Google Scholar]
196. Hertoghe T. The “multiple hormone deficiency” theory of aging: is human senescence caused mainly by multiple hormone deficiencies? Ann N Y Acad Sci. 2005;1057:448–65. doi:10.1196/annals.1322.035. [PubMed] [CrossRef] [Google Scholar]
197. Cranney A, Papaioannou A, Zytaruk N, Hanley D, Adachi J, Goltzman D, et al.Clinical Guidelines Committee of Osteoporosis Canada Parathyroid hormone for the treatment of osteoporosis: a systematic review. CMAJ. 2006;175:52–9. doi:10.1503/cmaj.050929. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
198. Vitetta L, Anton B. Lifestyle and nutrition, caloric restriction, mitochondrial health and hormones: scientific interventions for anti-aging. Clin Interv Aging. 2007;2:537–43. [PMC free article] [PubMed] [Google Scholar]
199. Heutling D, Lehnert H. [Hormone therapy and anti-aging: is there an indication?] Internist (Berl) 2008;49:570–80, 572-6, 578-9. doi:10.1007/s00108-008-2110-3. [PubMed] [CrossRef] [Google Scholar]
200. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994;78:1360–7. doi:10.1210/jc.78.6.1360. [PubMed] [CrossRef] [Google Scholar]
201. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000;97:4279–84. doi:10.1073/pnas.97.8.4279. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
202. Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab. 2006;91:2986–93. doi:10.1210/jc.2005-2484. [PubMed] [CrossRef] [Google Scholar]
203. Nair KS, Rizza RA, O’Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355:1647–59. doi:10.1056/NEJMoa054629. [PubMed] [CrossRef] [Google Scholar]
204. Wetterberg L, Bergiannaki JD, Paparrigopoulos T, von Knorring L, Eberhard G, Bratlid T, et al. Normative melatonin excretion: a multinational study. Psychoneuroendocrinology. 1999;24:209–26. doi:10.1016/S0306-4530(98)00076-6. [PubMed] [CrossRef] [Google Scholar]
205. Roth GS, Lesnikov V, Lesnikov M, Ingram DK, Lane MA. Dietary caloric restriction prevents the age-related decline in plasma melatonin levels of rhesus monkeys. J Clin Endocrinol Metab. 2001;86:3292–5. doi:10.1210/jc.86.7.3292. [PubMed] [CrossRef] [Google Scholar]
206. Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, et al. Neuroendocrine features in extreme longevity. Exp Gerontol. 2008;43:88–94. doi:10.1016/j.exger.2007.06.010. [PubMed] [CrossRef] [Google Scholar]
207. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005;27:179–88. doi:10.1385/ENDO:27:2:179. [PubMed] [CrossRef] [Google Scholar]
208. Heutling D, Lehnert H. [Hormone therapy and menopause] Dtsch Med Wochenschr. 2005;130:829–34. doi:10.1055/s-2005-865097. [PubMed] [CrossRef] [Google Scholar]
